Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 93, Issue 8, 2004, Pages 1064-1066

  Reinhard, Wibke ^b   Ten Cate, Folkert J ^a   Scholten, Marcoen ^b   De Laat, Lotte E ^b   Vos, Jeroen ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; NONSURGICAL SEPTAL REDUCTION; PRIORITY JOURNAL; REMISSION; THERAPY;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; ETHANOL; FEMALE; HEART BLOCK; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION;

EID: 1842789044     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.12.065     Document Type: Article

References (12)

1. Maron B.J., Bonow R.O., Cannon R.O., Leon M.B., Epstein S.E. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 316:1987;844-852.
2. Maron B.J. Hypertrophic cardiomyopathy, a systemic review. JAMA. 287:2002;1308-1320.
3. Morrow A.G., Reitz B.A., Epstein S.E., Henry W.L., Conkle D.M., Itscoitz S.B., Redwood D.R. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation. 52:1975;88-102.
4. Rydén L., Gadler F. Pharmacological therapy for hypertrophic cardiomyopathy what is the evidence for success? Eur Heart J. (suppl):2001;L21-L25.
5. Sigwart U. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
6. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1087.
7. Lakkis N.M., Nagueh S.F., Dunn J.K., Killip D., Spencer W.H. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy one-year follow-up. J Am Coll Cardiol. 36:2000;852-855.
8. Spencer W.H., Roberts R. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 102:2000;600-601.
9. Kuhn H. Fünf jahre TASH (Transkoronare Ablation der Septum Hypertrophie), eine Bilanz. Z Kardiol. 89:2000;559-564.
10. Sigwart U. Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy. Eur Heart J. 3:(suppl):2001;L38-L42.
11. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 31:1998;252-258.
12. Chang S.M., Nagueh S.F., Spencer W.H., Lakkis N.M. Complete heart block determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 42:2003;296-300.